our products
Contact phone

Galvus

Diabetes Galvus (Generic) Generic drugs, marketed without brand names, contain the exact same active ingredients used in their brand-name counterparts, but cost significantly less. The drugs are required to meet US Food and Drug Administration (FDA) standards for safety, purity and effectiveness.
Galvus

Galvus is a pharmaceutical product that is loaded with the active ingredient vildagliptin. Tablets are one form it can take (50 mg). Galvus is a medication that is used to treat diabetes mellitus type 2. It can be used on its own (monotherapy) in patients whose diabetes is not sufficiently controlled by diet and exercise and who are unable to take metformin. It can also be used in combination with metformin, a thiazolidinedione, or a sulphonylurea (dual therapy) in patients whose diabetes is not adequately controlled by these other medications when they are taken alone; however, it is only used in combination with a sulphonylurea As well, it is used together with a sulphonylurea and metformin (triple therapy) in patients whose diabetes is not sufficiently controlled by these medicines plus diet and exercise; additionally, it is used together with insulin (with or without metformin) in patients whose diabetes is not sufficiently controlled by diet and exercise plus a stable dose of insulin. Lastly, it is used together with a stable dose of insulin in patients whose diabetes is not sufficiently controlled by diet and exercise alone.

BEST DEAL!

Save 20% with

Coupon "PKVCbYFj9G"

Vildagliptin tablets Vildagliptin is an acronym for what? Vildagliptin is the component that provides the therapeutic effect in the medication known as Galvus Generic. Tablets are one form it can take (50 mg). What is the purpose of taking Vildagliptin? Vildagliptin is a medication that is used to treat diabetes mellitus type 2. It is only used in combination with a sulphonylurea in patients who are unable to take metformin. On its own (monotherapy) in patients whose diabetes is not sufficiently controlled by diet and exercise and who cannot take metformin; in combination with metformin, a thiazolidinedione or a sulphonylurea (dual therapy) when the patient's diabetes is insufficiently controlled by this other medicine taken alone; in combination with Indication for Medical Treatment Vildagliptin is indicated for the treatment of type-2 diabetes mellitus in adults in the following ways: as monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance; as dual oral therapy in combination with metformin, in patients with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin; as dual oral therapy in combination with a sulphonylurea Vildagliptin is used in the following ways: Vildagliptin's recommended dosage for adults is as follows: one tablet in the morning and another in the evening (100 mg per day), when used alone, with metformin, with a thiazolidinedione, with metformin plus a sulphonylurea, or with insulin (with or without metformin); one tablet in the morning (50 mg per day) when taken with a sulphonylurea. For children and adolescents, the recommended To further lessen the likelihood of hypoglycemia, one option is to take a lower dose of the sulphonylurea medication (low blood glucose levels). It is not recommended to take more than two pills each day (100 mg). Those who have moderate or severe renal difficulties should take 50 mg once day of this medication at the prescribed dose. How does Vildagliptin work? Diabetes type 2 is a disease that occurs when the pancreas does not produce enough insulin to control the level of glucose (sugar) in the blood or when the body is unable to effectively use insulin produced by the pancreas. Type 2 diabetes can also occur when the pancreas does not produce enough insulin. Vildagliptin is a dipeptidyl-peptidase-4 (DPP-4) inhibitor. This means that vildagliptin is the active ingredient in the medication. It accomplishes this by preventing the breakdown of hormones in the body known as incretins. After eating, these hormones are secreted, which in turn stimulates the production of insulin by the pancreas. When blood glucose levels are high, vildagliptin works to stimulate the pancreas into producing more insulin by elevating the amounts of incretin hormones that are already present in the blood. Vildagliptin is ineffective when there is a low level of glucose in the blood. Vildagliptin also decreases the amount of glucose that is produced by the liver. It does this by raising insulin levels and lowering glucagon levels. These mechanisms bring to a general decrease in blood glucose levels and contribute to the management of type 2 diabetes. What are the potential side effects of taking Vildagliptin? Dizziness is the most prevalent adverse reaction to vildagliptin, occurring in between 1 and 10 individuals out of every 100 who take the medication. See the product brochure for a complete listing of all of the adverse effects that have been associated with Vildagliptin, including the adverse effects that have been seen when Vildagliptin is combined with other diabetic medications. Contraindications Vildagliptin should not be administered to patients who have a history of hypersensitivity (allergy) to either vildagliptin itself or any of the other components of the medication. Patients should have tests to assess their liver function before beginning medication with vildagliptin and at frequent intervals while they are receiving treatment with vildagliptin. This is because vildagliptin has been related with liver issues. More details may be found here. Please check with your doctor or other healthcare professional to confirm that the information contained on this page is applicable to your specific situation before acting upon it.

Testimonials

high quality medications

Free discreet shipping

Secure online transactions

Money-back guarantee

Fast worldwide delivery

By staying on our site you automatically agree with the storage and processing of your personal data, in accordance with our Privacy Policy.